163 related articles for article (PubMed ID: 21356353)
1. Association of FABP5 expression with poor survival in triple-negative breast cancer: implication for retinoic acid therapy.
Liu RZ; Graham K; Glubrecht DD; Germain DR; Mackey JR; Godbout R
Am J Pathol; 2011 Mar; 178(3):997-1008. PubMed ID: 21356353
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability.
Powell CA; Nasser MW; Zhao H; Wochna JC; Zhang X; Shapiro C; Shilo K; Ganju RK
Oncotarget; 2015 Mar; 6(8):6373-85. PubMed ID: 25779666
[TBL] [Abstract][Full Text] [Related]
3. The cancer-promoting gene fatty acid-binding protein 5 (FABP5) is epigenetically regulated during human prostate carcinogenesis.
Kawaguchi K; Kinameri A; Suzuki S; Senga S; Ke Y; Fujii H
Biochem J; 2016 Feb; 473(4):449-61. PubMed ID: 26614767
[TBL] [Abstract][Full Text] [Related]
4. CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid.
Liu RZ; Garcia E; Glubrecht DD; Poon HY; Mackey JR; Godbout R
Mol Cancer; 2015 Jul; 14():129. PubMed ID: 26142905
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinoma.
Jeong CY; Hah YS; Cho BI; Lee SM; Joo YT; Jung EJ; Jeong SH; Lee YJ; Choi SK; Ha WS; Park ST; Hong SC
Oncol Rep; 2012 Oct; 28(4):1283-92. PubMed ID: 22825302
[TBL] [Abstract][Full Text] [Related]
6. E-FABP induces differentiation in normal human keratinocytes and modulates the differentiation process in psoriatic keratinocytes in vitro.
Dallaglio K; Marconi A; Truzzi F; Lotti R; Palazzo E; Petrachi T; Saltari A; Coppini M; Pincelli C
Exp Dermatol; 2013 Apr; 22(4):255-61. PubMed ID: 23528210
[TBL] [Abstract][Full Text] [Related]
7. A fatty acid-binding protein 7/RXRβ pathway enhances survival and proliferation in triple-negative breast cancer.
Liu RZ; Graham K; Glubrecht DD; Lai R; Mackey JR; Godbout R
J Pathol; 2012 Nov; 228(3):310-21. PubMed ID: 22322885
[TBL] [Abstract][Full Text] [Related]
8. Molecular determinants of retinoic acid sensitivity in pancreatic cancer.
Gupta S; Pramanik D; Mukherjee R; Campbell NR; Elumalai S; de Wilde RF; Hong SM; Goggins MG; De Jesus-Acosta A; Laheru D; Maitra A
Clin Cancer Res; 2012 Jan; 18(1):280-9. PubMed ID: 22010213
[TBL] [Abstract][Full Text] [Related]
9. FABP5 as a novel molecular target in prostate cancer.
O'Sullivan SE; Kaczocha M
Drug Discov Today; 2020 Sep; ():. PubMed ID: 32966866
[TBL] [Abstract][Full Text] [Related]
10. FABP5 coordinates lipid signaling that promotes prostate cancer metastasis.
Carbonetti G; Wilpshaar T; Kroonen J; Studholme K; Converso C; d'Oelsnitz S; Kaczocha M
Sci Rep; 2019 Dec; 9(1):18944. PubMed ID: 31831821
[TBL] [Abstract][Full Text] [Related]
11. Genetic ablation of the fatty acid-binding protein FABP5 suppresses HER2-induced mammary tumorigenesis.
Levi L; Lobo G; Doud MK; von Lintig J; Seachrist D; Tochtrop GP; Noy N
Cancer Res; 2013 Aug; 73(15):4770-80. PubMed ID: 23722546
[TBL] [Abstract][Full Text] [Related]
12. Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins.
Guaita-Esteruelas S; Bosquet A; Saavedra P; Gumà J; Girona J; Lam EW; Amillano K; Borràs J; Masana L
Mol Carcinog; 2017 Jan; 56(1):208-217. PubMed ID: 27061264
[TBL] [Abstract][Full Text] [Related]
13. Robust enumeration of cell subsets from tissue expression profiles.
Newman AM; Liu CL; Green MR; Gentles AJ; Feng W; Xu Y; Hoang CD; Diehn M; Alizadeh AA
Nat Methods; 2015 May; 12(5):453-7. PubMed ID: 25822800
[TBL] [Abstract][Full Text] [Related]
14. Fatty-acid-induced FABP5/HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells.
Seo J; Jeong DW; Park JW; Lee KW; Fukuda J; Chun YS
Commun Biol; 2020 Oct; 3(1):638. PubMed ID: 33128030
[TBL] [Abstract][Full Text] [Related]
15. FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism.
Zhang C; Liao Y; Liu P; Du Q; Liang Y; Ooi S; Qin S; He S; Yao S; Wang W
Theranostics; 2020; 10(15):6561-6580. PubMed ID: 32550890
[TBL] [Abstract][Full Text] [Related]
16. Fatty acid binding protein 5 suppression attenuates obesity-induced hepatocellular carcinoma by promoting ferroptosis and intratumoral immune rewiring.
Sun J; Esplugues E; Bort A; Cardelo MP; Ruz-Maldonado I; Fernández-Tussy P; Wong C; Wang H; Ojima I; Kaczocha M; Perry R; Suárez Y; Fernández-Hernando C
Nat Metab; 2024 Apr; 6(4):741-763. PubMed ID: 38664583
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid-binding protein 5 is a functional biomarker and indicator of ferroptosis in cerebral hypoxia.
Peng H; Xin S; Pfeiffer S; Müller C; Merl-Pham J; Hauck SM; Harter PN; Spitzer D; Devraj K; Varynskyi B; Arzberger T; Momma S; Schick JA
Cell Death Dis; 2024 Apr; 15(4):286. PubMed ID: 38653992
[TBL] [Abstract][Full Text] [Related]
18. A Retrospective View of the Triple-Negative Breast Cancer Microenvironment: Novel Markers, Interactions, and Mechanisms of Tumor-Associated Components Using Public Single-Cell RNA-Seq Datasets.
Kim M; Yang W; Hong D; Won HS; Yoon S
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539508
[TBL] [Abstract][Full Text] [Related]
19. SBFI26 induces triple-negative breast cancer cells ferroptosis via lipid peroxidation.
He G; Zhang Y; Feng Y; Chen T; Liu M; Zeng Y; Yin X; Qu S; Huang L; Ke Y; Liang L; Yan J; Liu W
J Cell Mol Med; 2024 Apr; 28(7):e18212. PubMed ID: 38516826
[TBL] [Abstract][Full Text] [Related]
20. Integrating single-cell and bulk transcriptomic analyses to develop a cancer-associated fibroblast-derived biomarker for predicting prognosis and therapeutic response in breast cancer.
Li C; Yang L; Zhang Y; Hou Q; Wang S; Lu S; Tao Y; Hu W; Zhao L
Front Immunol; 2023; 14():1307588. PubMed ID: 38235137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
